Company: BWAY
Filing Date: 2025-04-22
Form Type: 20-F
Source: 0001171843-25-002347
Chunk: 58

Company: Brainsway Ltd.
Filing Date: 2025-04-22
Form: 20-F
Item: Item 5
Chunk 58
---
 or we will
have the resources to defend against charges of patent infringement or other violation or misappropriation of intellectual property by
third parties or to protect our own intellectual property rights against infringement, misappropriation or violation by third parties.

Because the patent position of medical device companies
involves complex legal and factual questions, we cannot predict the validity and enforceability of patents with certainty. Changes in
either the patent laws or in interpretations of patent laws may diminish the value of our intellectual property. Accordingly, we cannot
predict the breadth of claims that may be allowable or enforceable in our patents (including patents owned by or licensed to us). Our
issued patents may not provide us with any competitive advantages, may be held invalid or unenforceable as a result of legal challenges
by third parties or could be circumvented. Our competitors may also independently develop formulations, processes, technologies, methods
or products similar to ours or design around or otherwise circumvent patents issued to, or licensed by, us. Thus, any patents that we
own or license from others may not provide any protection against competitors. Our pending patent applications, those we may file in the
future or those we may license from third parties may not result in patents being issued. If these patents are issued, they may not be
of sufficient scope to provide us with meaningful protection. The degree of future protection to be afforded by our proprietary rights
is uncertain because legal means afford relatively limited protection, and may not adequately protect our rights or permit us to gain
or keep our competitive advantage.

Patent rights are territorial; thus, the patent protection
we do have exists only in those countries in which we have been issued patents. Even so, the laws of certain countries do not protect
our intellectual property rights to the same extent as do the laws of the United States and the European Union. Therefore, we cannot assure
you that the patents issued to us or to our licensors, if any, as a result of foreign patent applications will have the same scope of
coverage as our or our licensors’ U. S. patents. Competitors may successfully challenge our patents, produce similar products that
do not infringe our patents, or produce products in countries where we have not applied for patent protection or that do not respect our
patents. Furthermore, it is not possible to know the scope of claims that will be allowed in published applications and it is also not
possible to know which claims of granted patents, if any, will be deemed enforceable in